Biapenem
![]() | |
Systematic (IUPAC) name | |
---|---|
(4R,5S,6S)-3-(6,7-dihydro-5H- pyrazolo[1,2-a][1,2,4]triazol-8- ium-6-ylsulfanyl)- 6-(1-hydroxyethyl)- 4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylate | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
Legal status |
|
Identifiers | |
CAS Number |
120410-24-4 ![]() |
ATC code | J01DH05 (WHO) |
PubChem | CID 71339 |
ChemSpider |
64442 ![]() |
UNII |
YR5U3L9ZH1 ![]() |
ChEBI |
CHEBI:3089 ![]() |
ChEMBL |
CHEMBL285347 ![]() |
Chemical data | |
Formula | C15H18N4O4S |
Molar mass | 350.39 g/mol |
| |
| |
(verify) |
Biapenem (INN) is a carbapenem antibiotic. It has in vitro activity against anaerobes.[1] 1-β-methyl-carbapenem antibiotic. Approved in Japan in 2001.
References
- ↑ Aldridge KE, Morice N, Schiro DD (April 1994). "In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes". Antimicrob. Agents Chemother. 38 (4): 889–93. doi:10.1128/aac.38.4.889. PMC 284564. PMID 8031067.
External links
- (Japanese) Omegacin
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.